Comparing end-of-life care in hospitalized patients with chronic obstructive pulmonary disease with and without palliative care in Taiwan

Journal of Research in Medical Sciences

Volumn 18, Issue 7, 2013, Pages 593-599

  Chou, Wen Chi ^a,b   Lai, Yu Te ^a   Hung, Yu Shin ^b  

^a SAINT PAUL S HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Chronic obstructive pulmonary disease; End of life; Palliative care

Indexed keywords

ANTIBIOTIC AGENT; INOTROPIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; SEDATIVE AGENT; STEROID;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COST OF ILLNESS; DEATH; DYSPNEA; FEEDING APPARATUS; FEMALE; FOLEY BALLOON CATHETER; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; INVASIVE PROCEDURE; MALE; PALLIATIVE THERAPY; REIMBURSEMENT; RESUSCITATION; RETROSPECTIVE STUDY; SURVIVAL RATE; TAIWAN; TERMINAL CARE;

EID: 84882966239     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. GOLD Scientific Committee: Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease, NHLBI/WHO Workshop Summary. Am J Respir Crit Care Med 2001;163:1256-76.
2. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997;349:1269-76.
3. Wang YC, Lin JM, Li CY, Lee LT, Guo YL, Sung FC. Prevalence and risks of chronic airway obstruction: A population cohort study in Taiwan. Chest 2007;131:705-10.
4. Au DH, Udris EM, Fihn SD, McDonell MB, Curtis JR. Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. Arch Intern Med 2006;166:326-31.
5. Zvezdin B, Milutinov S, Kojicic M, Hadnadjev M, Hromis S, Markovic M, et al. A postmortem analysis of major causes of early death in patients hospitalized with COPD exacerbation. Chest 2009;136:376-80.
6. Selecky PA, Eliasson CA, Hall RI, Schneider RF, Varkey B, McCaffree DR. American College of Chest Physicians: Palliative and end-of-life care for patients with cardiopulmonary diseases: American College of Chest Physicians position statement. Chest 2005;12:3599-610.
7. National Clinical Guideline Centre. Chronic obstructive pulmonary disease: Management of chronic obstructive pulmonary disease in adults in primary and secondary care Update guideline. Available from: http://guidance.nice.org.uk/CG101. [Last accessed on 2012 Jan 10].
8. O'Donnell DE, Aaron S, Bourbeau J, Hernandez P, Marciniuk D, Balter M, et al. Canadian Thoracic Society: Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease-2003. Can Respir J 2003;10:11A-65.
9. National Consensus Project for Quality Palliative Care: Clinical Practice Guidelines for quality palliative care, executive summary. J Palliat Med 2004;7:611-27.
10. The Hospice and Palliative Medicine National Consensus Guidelines, 2004. Available from: http://www.nationalconsensusproject.org. [Last accessed on 2011 Dec 10].
11. Global Strategy for the Diagnosis, Management and prevention of Chronic Obstructive Pulmonary Disease 2009. Global Initiative for Chronic obstructive Lung Disease (GOLD). Available from: http:// www.goldcopd.com. [Last accessed on 2011 Dec 10]
12. Hung YS, Chen CH, Yey KY, Chang H, Huang YC, Chang CL, et al. Potential benefits of palliative care for polysymptomatic late-stage nonmalignant patients in Taiwan. J Formos Med Assoc [In Press].
13. Chiu TY, Hu WY, Chen CY. Prevalence and severity of symptoms in terminal cancer patients: A study in Taiwan. Support Care Cancer 2000;8:311-3.
14. Tsai JS, Wu CH, Chiu TY, Hu WY, Chen CY. Symptom patterns of advanced cancer patients in a palliative care unit. Palliat Med 2006;20:617-22.
15. Wu SC, Chen JS, Wang MH, Hung YN, Liu TW, Tang ST. Determinants of ICU care in the last month of life for Taiwanese cancer decedents, 2001-2006. Chest 2010;138:1071-7.
16. Clarke EB, Curtis JR, Luce JM, Levy M, Danis M, Nelson J, et al. Robert Wood Johnson Foundation Critical Care End-Of-Life Peer Workgroup Members: Quality indicators for end-of-life care in the intensive care unit. Crit Care Med 2003;31:2255-62.
17. Edmonds P, Karlsen S, Khan S, Addington-Hall J. A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med 2001;15:287-95.
18. Bausewein C, Booth S, Gysels M, Kühnbach R, Haberland B, Higginson IJ. Understanding breathlessness: Cross-sectional comparison of symptom burden and palliative care needs in chronic obstructive pulmonary disease and cancer. J Palliat Med 2010;13:1109-18.
19. Blinderman CD, Homel P, Billings JA, Tennstedt S, Portenoy RK. Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manage 2009;38:115-23.
20. Jablonski A, Gift A, Cook KE. Symptom assessment of patients with chronic obstructive pulmonary disease. West J Nurs Res 2007;29:845-63.
21. Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax 2000;55:1000-6.
22. Tranmer JE, Heyland D, Dudgeon D, Groll D, Squires-Graham M, Coulson K. Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale. J Pain Symptom Manage 2003;25:420-9.
23. Lau KS, Tse DM, Tsan Chen TW, Lam PT, Lam WM, Chan KS. Comparing noncancer and cancer deaths in Hong Kong: A retrospective review. J Pain Symptom Manage 2010;40:704-14.
24. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 2006;31:58-69.
25. Claessens MT, Lynn J, Zhong Z, Desbiens NA, Phillips RS, Wu AW, et al. Dying with lung cancer or chronic obstructive pulmonary disease: Insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc 2000;48:S146-53.
26. Abrahm JL, Hansen-Flaschen J. Hospice care for patients with advanced lung disease. Chest 2002;121:220-9.
27. Lynn J, Ely EW, Zhong Z, McNiff KL, Dawson NV, Connors A, et al. Living and dying with chronic obstructive pulmonary disease. J Am Geriatr Soc 2000;48:S91-100.
28. Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Patterns of functional decline at the end of life. JAMA 2003;289:2387-92.
29. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12.
30. Connors AF Jr, Dawson NV, Thomas C, Harrell FE Jr, Desbiens N, Fulkerson WJ, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996;154:959-67.
31. Heyland DK, Dodek P, Rocker G, Groll D, Gafni A, Pichora D, et al. Canadian Researchers End-of-Life Network (CARENET): What matters most in end-of-life care: Perceptions of seriously ill patients and their family members. CMAJ 2006;174: 627-33.
32. nd ed. Arlington, VA: NHPCO; 1996.
33. Coventry PA, Grande GE, Richards DA, Todd CJ. Prediction of appropriate timing of palliative care for older adults with non-malignant life-threatening disease: A systematic review. Age Ageing 2005;34:218-27.
34. Christakis NA, Lamont EB. Extent and determinants of error in doctor's prognosis in terminally ill patients: Prospective cohort study. BMJ 2000;320:469-72.